|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2003-4-3
|
|
pubmed:abstractText |
Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-occlusive complications in patients with sickle cell anemia (SCA). High HbF levels reduce morbidity and mortality.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:AdlerBrianB,
pubmed-author:AtagaKennethK,
pubmed-author:BallasSamir KSK,
pubmed-author:BartonFrancaF,
pubmed-author:BellevueRitaR,
pubmed-author:BigelowCarolynC,
pubmed-author:BondsDuaneD,
pubmed-author:BridgesKennethK,
pubmed-author:CarlosTimothyT,
pubmed-author:CastroOswaldoO,
pubmed-author:ClasterSusanS,
pubmed-author:DeCastroLauraL,
pubmed-author:EckmanJamesJ,
pubmed-author:KutlarAbdullahA,
pubmed-author:OlivieriNancyN,
pubmed-author:OrringerEugeneE,
pubmed-author:PegelowCharles HCH,
pubmed-author:RamirezGloriaG,
pubmed-author:SaunthararajahYogenY,
pubmed-author:ShurinSusanS,
pubmed-author:SmithWallyW,
pubmed-author:SteinbergMartin HMH,
pubmed-author:TelferMargaretM,
pubmed-author:TerrinMichaelM,
pubmed-author:VarmaMalaM,
pubmed-author:VichinskyElliottE,
pubmed-author:WaclawiwMyronM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
2
|
|
pubmed:volume |
289
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1645-51
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12672732-Adult,
pubmed-meshheading:12672732-Anemia, Sickle Cell,
pubmed-meshheading:12672732-Antisickling Agents,
pubmed-meshheading:12672732-Blood Cell Count,
pubmed-meshheading:12672732-Cause of Death,
pubmed-meshheading:12672732-Double-Blind Method,
pubmed-meshheading:12672732-Fetal Hemoglobin,
pubmed-meshheading:12672732-Follow-Up Studies,
pubmed-meshheading:12672732-Humans,
pubmed-meshheading:12672732-Hydroxyurea,
pubmed-meshheading:12672732-Morbidity,
pubmed-meshheading:12672732-Risk Assessment,
pubmed-meshheading:12672732-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
|
|
pubmed:affiliation |
Boston University School of Medicine, Center of Excellence in Sickle Cell Disease, Boston Medical Center, Boston, Mass 02118, USA. msteinberg@medicine.bu.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
